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Postnatal development and progression of renal dysplasia in Prostaglandins, most widely known as inflammatory
cyclooxygenase-2 null mice. mediators, also regulate vascular contractility and salt and
Background. Genetic ablation of cyclooxygenase-2 (COX-2) water balance within the kidney. Prostaglandins, prosta-resulted in cystic renal dysplasia and early death in adult mice.
cyclin, and thromboxane are produced from the interme-The ontologic development of the renal pathology and the
diate prostaglandin H2 by the conversion of membrane-biochemical and physiological abnormalities associated with
the dysplasia are unknown. derived arachidonic acid by the enzymatic activity of
Methods. Mice homozygous for a targeted deletion of COX-2 prostaglandin G2/H2 synthase, also referred to as cyclo-(2/2) were compared with wild-type littermates (1/1). Somatic oxygenase (COX). COX exists as two isoforms, COX-1and kidney growth and renal histology were studied at the day
and COX-2, which are produced from two differentof birth and at a number of postnatal ages. Systolic blood
pressure, urinalysis, urine osmolality, serum and urine chemis- genes (in the mouse, Ptgs1 and Ptgs2). COX-1 is ubiqui-
tries, and inulin clearance were evaluated in adult animals. tously expressed throughout most mammalian tissues,
Results. Beginning at postnatal day 10 (PN10), kidney growth primarily in stomach, platelets, and vasculature. Within
was suppressed in 2/2 animals, while somatic growth and
the kidney, it is reportedly expressed within the vascularheart growth were unaffected. By PN10, 2/2 kidneys had thin
endothelium, medullary collecting ducts, and medullarynephrogenic cortexes and crowded, small, subcapsular glomer-
uli. The pathology increased with age with progressive outer interstitium [1, 2]. The production of prostanoids by
cortical dysplasia, cystic subcapsular glomeruli, loss of proximal COX-1, thought to be the primary mechanism of prosta-
tubular mass, and tubular atrophy and cyst formation. Adult noid production within the kidney, is usually constitutive
2/2 kidneys had profound diffuse tubular cyst formation, outer
with fairly constant levels of enzyme activity [1]. Unlikecortical glomerular hypoplasia and periglomerular fibrosis, in-
COX-1, COX-2 is undetectable in most tissues, but canner cortical nephron hypertrophy, and diffuse interstitial fibro-
sis. The glomerular filtration rate was reduced by more than be induced by a variety of inflammatory cytokines in mac-
50% in 2/2 animals (6.82 6 0.65 mL/min/kg) compared with rophages, brain, chondrocytes, fibroblasts, and synovial
wild-type controls (14.7 6 1.01 mL/min/kg, P , 0.001). Plasma
cells [1]. Within the rat kidney, COX-2 has been localizedblood urea nitrogen and creatinine were elevated in null ani-
to macula densa, cortical thick ascending limb, and papil-mals compared with controls. Blood pressure, urinalysis, urine
osmolality, and other plasma chemistries were unaffected by lary interstitium and is induced by salt restriction [3, 4].
the deletion of COX-2. In 1995, both isoforms of COX were independently
Conclusions. Deficiency of COX-2 results in progressive and inactivated in mice using homologous recombination. Dis-specific renal architectural disruption and functional deterioration
ruption of the COX-1 gene resulted in decreased plateletbeginning in the final phases of nephrogenesis. Tissue-specific
aggregation and a decreased inflammatory response toand time-dependent expression of COX-2 appears necessary
for normal postnatal renal development and the maintenance arachidonic acid [5]. No obvious renal abnormalities
of normal renal architecture and function. were seen. Deletion of COX-2, however, produced a
strikingly different phenotype [6, 7]. While inflammatory
responses were surprisingly normal, severe renal pathol-
ogy was present in adult homozygous null mutant (2/2)
animals. These animals often died early, and histopatho-
logic examination of the kidneys revealed profound cys-Key words: nephrogenesis, eicosanoids, cystic renal dysplasia, postna-
tal kidney development, Ptgs2 gene, toxic COX-2 blockade. tic dysplasia.
While these genetic manipulations clearly indicate thatReceived for publication February 15, 2000
COX-2 activity is critical for the maintenance of normaland in revised form June 6, 2000
Accepted for publication June 27, 2000 renal architecture, the time of presentation and physio-
logical consequences of these abnormalities is unknown.Ó 2000 by the International Society of Nephrology
2291
Norwood et al: Renal dysplasia in COX-2–deficient mice2292
The object of the current studies was to determine the altered gene as a band at 2.6 kb, while the targeted gene
ontologic development and progression of the renal dys- was detected at 3.8 kb. Line 2 was genotyped by detection
plasia seen in COX-2–deficient mice and to assess the using a polymerase chain reaction strategy. Using three
biochemical and physiological abnormalities associated primers, two specific for the unaltered Ptgs2 gene (A,
with the pathology. 59-GCC ACC TCC GCT GCC ACC TCT GCG A-39,
and B, 59-CAT ACA TTC CCC ACG GTT TTG A-39)
and another specific for the inserted neomycin-resistanceMETHODS
cassette (C, 59-GAT TCG CAG CGC ATC GCC TTC-39),
Animals thermal cycling amplification was performed by melting
Breeding colonies of two previously described mouse at 948C for 45 seconds, annealing at 608C for 1 minute,
lines carrying targeted deletions of the COX-2 gene were and extension at 728C for 1 minute for 33 cycles. The
established at the University of Virginia (Charlottesville, wild-type gene was detected by gel electrophoresis as a
VA, USA). The first line (line 1), derived at the Univer- band at 800 bp, while the targeted gene was detected at
sity of North Carolina (Chapel Hill, NC, USA), contains 430 bp.
a 104 bp deletion of the Ptgs2 gene in exon 8 that elimi-
nates the nucleotides encoding the crucial Tyr-371 and Urinalysis and urine osmolality
His-374, both necessary for COX activity [6]. The second Random urine samples were obtained from adult mice
line (line 2), derived by Dinchuk et al [7], was purchased (N 5 7 each genotype, ages 14 to 20 weeks) for urinalysis
from the Induced Mutant Resource of Jackson Labora- using Multistixt 10 SG reagent strips (Bayer, Elkhart,
tories (Bar Harbor, ME, USA). This line contains a 220 IN, USA). Urine osmolality was determined by vapor
bp deletion within exon 1 of the Ptgs2 gene. Both lines pressure osmometry (Wescor, Logan, UT, USA).
were initially established as 129/C57BL6 chimeras and
were interbred into C57BL6 wild-type mice obtained Serum and urine chemistries
from Hilltop Labs (Scottsdale, PA, USA) to establish Plasma samples obtained at the time of sacrifice (ages
the colonies at the University of Virginia. F2 and F3 14 to 18 weeks) were utilized for analysis of sodium, potas-
heterozygous pairs were bred to obtain litters of pups sium, chloride, total CO2, and glucose using a NOVAcontaining wild-type (1/1), heterozygous (1/2), and 16 analyzer (NOVA Biomedical, Waltham, MA, USA).
homozygous mutant (2/2) littermates. Approximately Twenty-four–hour urine collections were assayed simi-
equal numbers of mice from lines 1 and 2 were used in
larly for sodium, potassium, and chloride. Plasma creati-the following studies. Animals were sacrificed at the day
nine was measured by the alkaline picrate colorimetricof birth (N 5 46) and at postnatal days 3 (PN3; N 5
assay (Sigma #555-A; Sigma Chemical Co., St. Louis, MO,65), 7 (N 5 52), 10 (N 5 44), 14 (N 5 87), 28 (N 5 47),
USA), and blood urea nitrogen (BUN) was measuredand 42 (N 5 50) for comparison of genotype expression,
colorimetrically using diacetyl monoxime (Sigma #535-A).body weight, total kidney weight, heart weight, and renal
histology. Kidneys from previously studied PN56 (8 Blood pressures
weeks) and PN112 (16 weeks) adult animals were also
Awake systolic blood pressures were measured by tailexamined for pathologic changes. Adult mice (ages 8
cuff in adult animals (N 5 12, each genotype) ages 8 to 14to 24 weeks) were utilized for determination of blood
weeks using a Visitech BP 2000 Blood Pressure Analysispressure, random urine osmolality, and inulin clearance,
System (Apex, NC, USA) [8]. All animals had two cyclesas described later in this article. Separate groups of adult
of 10 measurements recorded per day for a minimum ofmice were housed in metabolic cages for four days for
three days. Those animals undergoing inulin clearancedocumentation of water intake and collection of 24-hour
studies (described later in this article) had anesthetizedurine samples for volume and electrolyte determination.
intra-arterial blood pressures ascertained at the begin-The animals were then sacrificed for determination of
ning of the procedure.serum electrolytes as described later in this article. All
animals were maintained on Tekland 7012 rodent diet
Tissue preparation and light microscopyand had free access to tap water. Pups were nursed by
At the time of animal euthanasia using halothane, thetheir dams and were weaned at three weeks of age. All
kidneys were rapidly removed, weighed, hemisected, andprocedures were performed with the approval of the
fixed in Bouin’s solution or 10% buffered formalin. Fol-University of Virginia Animal Research Committee.
lowing embedding in paraffin, 5 to 7 mm sections were
Genotype analysis prepared and stained with hematoxylin and eosin, peri-
odic acid-Schiff (PAS), or Masson’s trichrome and wereGenotypes of mice from line 1 were determined by
examined under direct microscopy. A minimum of twoSouthern analysis as previously described [6]. Follow-
sections, at least 100 mm apart, were examined for eaching SacI digestion of tail DNA, hybridization with a
32P-labeled 1.9 kb COX-2 cDNA probe detected the un- kidney.
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Fig. 2. Somatic growth of wild-type (1/1; m) and COX-2 homozygous
null mutant (2/2; s) mice during the first six weeks of life. No significant
differences in body weight are apparent at any age.
Fig. 1. Distribution of genotypes at the Ptgs2 locus in mice sacrificed
at varying ages during the first six weeks of life. Wild-type (1/1; ),
heterozygous (1/2; h), and homozygous null (2/2; ) genotypes are
represented in the expected 1:2:1 ratios at all time points.
homozygous mutant (2/2) genotypes without differenti-
ating between the two targeting constructs.
Inulin clearance
Adult mice (16 to 24 weeks of age) had a glomerular RESULTS
filtration rate (GFR) measured by tritiated inulin clear- Genotypic ratios
ance as previously described [9]. Wild-type (N 5 5) and
Matings between heterozygous pairs produced new-homozygous null (N 5 6) animals were anesthetized
born progeny carrying all three expected genotypes inwith intraperitoneal pentobarbital (70 mg/kg) and were
the expected Mendelian proportions of 1:2:1 wild-type:placed on a thermostatically controlled heating table.
heterozygote:homozygous mutant (Fig. 1). The normalUnder continuous oxygen flow by tracheostomy tube, a
distribution of genotypes did not vary from expected
carotid artery was cannulated for blood withdrawal and
throughout the first six weeks of life (x2, P 5 0.38). The
mean arterial blood pressure monitoring. A jugular venous results indicate that a deficiency of COX-2 does not
catheter was used for continuous infusion of 3H-inulin result in fetal loss or in early postnatal death. Of the 90
(New England Nuclear, Danvers, MA, USA) at a dose of homozygous null animals studied in the first six weeks
1000 mCi/min/100 g body weight. A suprapubic bladder of life, there were 35 males and 55 females (x2, P 5
catheter was surgically placed for urine collection. After 0.177), suggesting that through early life, male and fe-
a 45-minute equilibration period, two 20-minute urine male animals with COX-2 deficiency survive equally
collections were made, and 0.1 mL blood collections well. During adulthood, however, there was clearly a
were made at the start of each period and at the end of difference in long-term survivability based on genotype.
the second urine collection. Blood samples were replaced Of animals allowed to survive longer than six weeks
with 4% bovine serum albumin. The radioactivity of of age, there were no spontaneous deaths in wild-type
plasma and urine aliquots was measured in a Beckman animals, while 12 of 58 homozygous null mice (20.7%)
LS6500 scintillation counter (Beckman Instruments, Ir- died between the ages of 7 and 23 weeks. Of these ani-
vine, CA, USA), and inulin clearance was calculated as mals, 8 were female and 4 were male.
the product of urine flow and urine to plasma activity
ratio (UV/P) corrected for body weight. Somatic and organ growth
The body weights of animals at ages of birth through
Statistical analysis 42 days are shown in Figure 2. There are no significant
Results were expressed as mean 6 SE. Chi-square differences between the somatic growth of homozygous
analysis was used to compare the distribution of geno- null mutant mice and their wild-type littermates at any
typic expression at the targeted locus to the 1:2:1 ratio of the ages studied, suggesting that COX-2 deficiency
of 1/1:1/2:2/2 animals expected by normal Mendelian does not affect normal postnatal growth.
inheritance. Comparisons of body and organ weights, Figure 3 shows the effect of COX-2 genotype on heart
blood pressure, blood and urine chemistries, and inulin growth during the first six weeks of life. With the excep-
clearance were made between wild-type and homozy- tion of birth, there are no differences in heart weight:
gous mutant mice using Student’s t-test. No differences body weight ratios during postnatal growth and early
in any of the study variables were identified between the adulthood. The significance of higher heart weight:body
two lines of mice, and the data have been consolidated weight ratios in newborn knockout pups is unclear.
The effect of COX-2 deficiency on kidney growth isto reflect only wild-type (1/1), heterozygous (1/2), and
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Fig. 3. Heart growth of wild-type (1/1; m) and COX-2 homozygous Fig. 4. Kidney growth of wild-type (1/1; m) and COX-2 homozygous
null mutant (2/2; s) mice during the first six weeks of life. During null mutant (2/2; s) mice during the first six weeks of life. By postnatal
postnatal development, heart growth is unaffected by genotype at the day 10 (PN10; *P , 0.001), kidney growth is suppressed in COX-2–
Ptgs2 locus. deficient animals compared with their wild-type littermates. This organ-
specific growth suppression persists throughout the remainder of devel-
opment.
shown in Figure 4. Beginning at PN10, total kidney mass
is markedly suppressed in homozygous null animals as
Blood pressurescompared with their wild-type littermates (P , 0.001).
No significant differences in awake systolic blood pres-This growth suppression persists throughout the remain-
sures were found in COX-2–deficient animals (100.7 6der of the preweanling period and early adulthood with-
2.4 mm Hg, N 5 12) as compared with wild-type controlsout significant change.
(96.4 6 1.3 mm Hg, N 5 12), suggesting that under
Renal histopathology unstressed conditions, COX-2 deficiency does not affect
resting blood pressure. Likewise, in anesthetized animalsNo differences in renal morphology were detected be-
at the initiation of the measurements for inulin clear-tween COX-2 2/2 mice and their 1/1 controls on the
ances, no differences were seen in intra-arterial systolicday of birth, PN3, and PN7 (data not shown). By PN10,
pressures in COX-2–deficient animals (87.3 6 7.8 mm Hg,early cystic changes were identifiable in some 2/2 kid-
N 5 6) as compared with wild-type controls (73.2 6neys affecting several different tubule sections and glo-
10.2 mm Hg, N 5 5).meruli, and crowded, small, subcapsular glomeruli were
noted (Fig. 5). A distinctive lack of the normal proximal
Daily water intake and urine outputtubular mantle was also noted in 2/2 animals. Not all
Twenty-four–hour urine collections (N 5 3 each ani-PN10 2/2 kidneys exhibited identifiable abnormalities,
mal) were obtained, and daily water intake was quanti-suggesting that the rate of pathologic progression may vary
tated after overnight equilibration in metabolic cages.slightly among animals. However, by PN14, all COX-2–
Table 1 shows that COX-2 deficiency does not causedeficient kidneys could be differentiated from their wild-
significant alterations in drinking behaviors and urinetype littermates. Kidneys from PN14 and PN28 2/2
output under nonstressed conditions.animals showed progressive outer cortical dysplasia with
cystic subcapsular glomeruli, loss of proximal tubular
Urinalysis and urine osmolalitymass and brush-border definition, and tubular atrophy
Table 2 illustrates that no significant abnormalitiesand cyst formation (Fig. 6). Hypertrophy of juxtamedul-
were found on random urinalysis in either genotype.lary glomeruli and tubules was notable by PN28. The
Likewise, spot urine osmolalities did not differ betweenseverity of pathological changes continued to increase
the groups (1/1 5 1573 6 252 mOsm/kg vs. 2/2 5with age. Adult (PN42) homozygous null kidneys had
1172 6 163 mOsm/kg, P 5 0.21). These results suggestprofound diffuse tubular dilation and cyst formation,
that COX-2 deficiency does not result in clinically detect-outer cortical glomerular hypoplasia and periglomerular
able hematuria, proteinuria, glycosuria, or extreme alter-fibrosis, focally variable glomerular sclerosis, inner corti-
ations in urinary concentrating capacity.cal nephron hypertrophy, and diffuse interstitial fibrosis
(Fig. 7). At no time point was significant inflammatory
Plasma and urine chemistriesinfiltrate or vascular pathology seen. Some degree of
variability in the severity of adult pathology was noted Table 3 includes the plasma electrolytes, urea nitrogen,
and creatinine values obtained from adult COX-2–defi-among littermates, with some animals showing more se-
vere cystic degeneration than others (Fig. 8). These dif- cient mice and their wild-type controls. Plasma sodium,
potassium, bicarbonate, and chloride were not differentferences were not related to gender or targeting strategy.
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Fig. 5. Renal morphology at PN10 (PAS staining). (A) Low-power view of 2/2 kidney with tubular dilation and early cystic changes (arrowheads).
(B) High-power view of 2/2 kidney showing crowding of glomeruli in the subcapsular region with loss of normal proximal tubular mantle. (C )
Wild-type littermate control. The subcapsular proximal tubular mantle is marked by arrows.
Fig. 6. Renal morphology at two and four weeks of age (PAS staining). (A) Severely affected 2/2 kidney at PN14 showing cortical disorganization,
loss of subcapsular tubular mass, glomerular cysts (arrowhead), and massive tubular cysts (double arrowheads). (B) Wild-type littermate control
at PN14. (C ) PN28 2/2 kidney. Note the loss of outer cortical tubular mass, tubular atrophy (arrowhead), and hypoplasia of outer glomeruli
compared with hyperplasia of juxtamedullary glomeruli. (D) Wild-type littermate control at PN28.
between the two groups, while both BUN and creatinine potassium, and chloride for COX-2–deficient mice and
their wild-type controls. When allowed free access to awere significantly elevated in animals lacking COX-2.
Plasma BUN was approximately 2.5-fold higher (79.2 6 normal diet and tap water, there were no significant differ-
ences in electrolyte excretion rates between the two groups.7.5 vs. 29.1 6 0.7 mg/dL, P , 0.001), and creatinine was
approximately 1.5-fold higher (0.49 6 0.06 vs. 0.29 6
Inulin clearance0.04 mg/dL, P 5 0.014) in knockout animals compared
with their wild-type controls. These results thus document Genotype at the Ptgs2 locus had profound effects on
GFR as measured by inulin clearance (Fig. 9). The GFRthat renal insufficiency is indeed a consequence of the
pathologic abnormalities seen in this disorder. of animals deficient in COX-2 was reduced approximately
50% (6.82 6 0.65 mL/min/kg body weight, N 5 6) com-Table 4 shows the daily urinary excretion of sodium,
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b
Fig. 7. Renal morphology in adult animals (PAS staining). (A) Sixteen-week-old 2/2 kidney showing widespread loss of architectural integrity,
outer cortical glomerular hypoplasia, inner glomerular hypertrophy and sclerosis, and interstitial fibrosis. (B) Wild-type littermate control.
pared with normal wild-type controls (14.7 6 1.01 mL/ and reduced glomerular diameter [11]. Further studies
min/kg body weight, N 5 5, P , 0.001). are necessary to determine whether this growth failure
is diffuse throughout the kidney or specific to particular
cell types or nephron structures. Dinchuk et al reportedDISCUSSION
a 50% incidence of diffuse myocardial fibrosis in their
While the COXs and their prostanoid products have adult null mice [7]. Although no microscopic analysis
important roles in cytoprotection, vascular homeostasis, was performed on the hearts in this report, there were
platelet function, and control of renal blood flow and clearly no differences in cardiac mass seen within the
water balance, the independent functions of COX-1 and first six weeks of life.
COX-2 in the kidney have remained elusive. Isozyme- Histologic analysis of the kidneys from infant, young,
specific pharmacologic inhibitors are currently in clinical and adult mice deficient in COX-2 documented a pro-
trials [10], but in the past have not been adequate for found progression of cystic dysplasia over time. Consis-
differentiation of the functions of the two isoforms with tent with Morham et al’s report [6], the kidneys of new-
respect to renal function. Targeted deletion of the genes born and three-day-old mice appeared normal. Dinchuk
by homologous recombination has provided excellent et al reported impressive cystic dysplasia at PN2 [7], a
insights into the importance of these enzymes in the
finding not documented in the F3 and F4 generation
kidney. Clearly, our studies show that functional COX-2
progeny of the current study. Other knockout modelsis necessary to achieve a normal mature renal phenotype
have shown variations in the phenotype with subsequentand maintain normal renal excretory activities, but is not
inbreeding [12], suggesting that the remaining geneticnecessary for early renal differentiation or fetal and early
environment of the mouse may impact the final pheno-postnatal survival. After maturation, COX-2 deficiency
type. Whether the abnormalities caused by deletion ofclearly results in lethality in some animals, with approxi-
Ptgs2 will improve, worsen, or remain unchanged withmately 20% of homozygous null animals dying between
further inbreeding remains to be seen. Certainly, therethe ages of 7 and 23 weeks. While Dinchuk et al also
is no evidence that the final pathway of progressive renalfound a high incidence of neonatal deaths not seen in
dysplasia and insufficiency in these mice is significantlyour breeding colony [7], the average lifespan of 2/2
alleviated by the third and fourth generations.animals was reported to be 3.5 months in their report,
It is important to consider the fact that prenatal andwhich is consistent with our findings. Similarly, the initial
early PN kidney development is normal in these micereport from our line of mice noted normal survival to
even though no COX-2 has been present in the mouseweaning but a number of deaths at approximately eight
itself throughout development of the animal. These resultsweeks of age [6]. Morham et al noted an unusually low
have recently been confirmed using a pharmacologic ap-number of male progeny of F1 matings carrying one
proach of prenatal and early postnatal COX-2 inhibitionor two mutated alleles [6]. The F3 and F4 generations
with SC58236. In these studies, Ko¨mhoff et al noted thatdescribed in this report contained a normal distribution
treatment throughout gestation caused no definable re-of male and female animals in all genotypes, suggesting
nal abnormalities at birth, while persistence of therapythat—at least in subsequent generations—there is no
through weaning resulted in histologic abnormalities ateffect of COX-2 deficiency on gender survival.
PN21 [11]. Several possibilities exist that might explainThis report documents an organ-specific renal growth
this phenomenon. COX-2 may not normally be expressedfailure induced by deletion of the Ptgs2 gene. While
during early nephrogenesis in the mouse, but expressionheart growth and body growth were unaffected, COX-2
may be required at a later time point to tailor the finaldeficiency resulted in an arrest of kidney growth begin-
stages of renal architectural development appropriately.ning at PN10. These results complement similar findings
However, COX-2 immunoreactivity has been found asby Ko¨mhoff et al in which pharmacologic inhibition of
COX-2 resulted in impaired renal cortical development early as E16 in the developing rat with increasing expres-
b
Fig. 8. Phenotypic variability in adult (8-week-old) 2/2 littermates. (A) Severe cystic degeneration with glomerular sclerosis and loss. (B)
Littermate of (A) without significant cystic changes. Outer cortical glomerular hypoplasia and inner nephron hypertrophy are consistently
demonstrated.
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Table 3. Plasma chemistriesTable 1. Daily water intake and urine output
Wild-type (1/1) Homozygous null (2/2) Wild-type (1/1) Homozygous null (2/2)
N 5 7 N 5 5N 5 6 N 5 4
Water intake cc/g/day 0.265560.022 0.265060.015 Sodium mEq/L 15261 14963
Potassium mEq/L 3.760.4 4.060.2Urine output cc/g/day 0.060560.0063 0.068860.008
Chloride mEq/L 12560.4 12560.6
Total CO2 mEq/L 15.360.7 15.460.6
Glucose mg/dL 17166 184616
BUN mg/dL 29.160.7 79.267.5a
(N510) (N513)
Table 2. Urinalysis and urine osmolality Creatinine mg/dL 0.2960.04 0.4960.06b
(N510) (N511)
Wild-type (1/1) Homozygous null (2/2)
a P , 0.001 vs. 1/1Urine N 5 7 N 5 7
b P 5 0.014 vs. 1/1
Blood Negative Negative
Protein Trace to 11 Trace to 11
Table 4. Urinary electrolyte excretion ratesSpecific gravity 1.01560.002 1.01560.002
Glucose Negative Negative
Wild-type (1/1) Homozygous null (2/2)pH 7.3160.06 7.2360.21
N 5 5 N 5 4Ketone Negative Negative
Bilirubin Negative Negative Sodium mEq/kg/day 8.5961.85 8.0461.94
Osmolality mOsm/kg 15736252 11726163 Potassium mEq/kg/day 12.7162.77 10.1061.88
Chloride mEq/kg/day 17.0263.66 13.3362.72
sion as ontogeny and maturation progress [3]. These
in the first week of life [15]. COX-2–deficient mice haveresults suggest the intriguing hypothesis that the function
been suggested as a model of oligomeganephronia be-of COX-2 in early renal development is not mandatory,
cause of the hypertrophy of the relatively unaffectedwhile later expression is necessary for terminal proc-
juxtamedullary nephrons [6]. The only described mouseessing. Alternative explanations for normal prenatal de-
model of this disorder is the Os/1 mouse, an autosomalvelopment include maintenance of normal eicosanoid
dominant mutation, that results in prenatal renal hypo-production by local COX-1 expression or circulation of
plasia, progressive hypertrophy of remaining nephrons,maternally produced prostanoids, either of which could
without cystic degeneration, and oligosyndactyly [16].support normal development. An additional explanation
COX-2–deficient mice, in contrast, have normal prenatalfor the development of progressive cystic dysplasia in the
renal growth, postnatal pathology, including cysts, andlater stages of renal development includes the potential
an autosomal recessive inheritance pattern. It appearstoxic effects of HETEs, leukotrienes, and cytochrome
that deficiency of COX-2 results in a unique form of renalP450 metabolites that may be elevated in the absence
maldevelopment that should provide important clues asof COX-2.
to the role of COX-2 in this complex process.The initial pathologic abnormalities seen in the 2/2
The pathologic changes seen in COX-2 deficient kid-animals included cyst formation in multiple nephron seg-
neys result in surprisingly few alterations in physiologicments, crowding of differentiating glomeruli, and poor
markers. Blood pressures are not different between 1/1tubule differentiation within a thin nephrogenic cortex.
and 2/2 animals, suggesting that prostanoid productsThese abnormalities suggest that a variety of cell types
of COX-2 activity do not regulate baseline blood pres-are affected by COX-2 deficiency, although a cascade
sure or that compensatory mechanisms completely abol-effect resulting from the alteration of a single precursor
ish the appearance of any effects. Likewise, baselinecell cannot be excluded. It is interesting to note that the
sodium and water balance is unaffected by COX-2 defi-progressive renal destruction in COX-2–deficient mice
ciency. Given the known roles of distal nephron prostan-is both similar and different to the abnormalities seen
oid activity to enhance sodium and water excretion, itin several murine kidney disease models. The cpk mouse
was anticipated that deletion of COX-2 would result inand the bpk mouse, both models of recessive cystic dis-
salt and water retention, much like that seen with nonste-ease, develop proximal tubular cysts in the late stages
roidal anti-inflammatory drug (NSAID) use. Whether saltof gestation and develop collecting duct cysts in the first
and water reabsorption is “normalized” by the destructionpostnatal week [13, 14]. Both lines die with massive renal
of normal tubular architecture has not been determined.enlargement and renal insufficiency by 25 to 28 days of
In fact, the only definable difference in baseline renalpostnatal life. Mice lacking the bcl-2 protooncogene also
function seen in COX-2–deficient mice is decreased GFRhave abnormal renal development and cystic degenera-
and resultant uremia. Given the degree of cystic degener-tion [15]. These kidneys are hypoplastic at birth and
exhibit cystic changes in all nephron segments beginning ation seen in these kidneys, this loss of functional capac-
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those seen in several human infants with renal failure
secondary to long-term NSAIDs in utero [17]. In addi-
tion, persistent renal insufficiency has been noted in pa-
tients receiving chronic ibuprofen for Bartter’s syndrome
[18]. It is therefore important to understand how COX-2
regulates renal development both as a means to under-
stand renal dysplasia and to protect the developing kid-
ney more adequately from the potentially permanent
toxic effects of COX-2 blockade.
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